384 related articles for article (PubMed ID: 16940085)
21. Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia.
Mansour W; Poirel L; Bettaieb D; Bouallegue O; Boujaafar N; Nordmann P
Microb Drug Resist; 2008 Dec; 14(4):289-92. PubMed ID: 19018672
[TBL] [Abstract][Full Text] [Related]
22. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
[TBL] [Abstract][Full Text] [Related]
23. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates.
Mugnier P; Poirel L; Pitout M; Nordmann P
Clin Microbiol Infect; 2008 Sep; 14(9):879-82. PubMed ID: 18844691
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of different carbapenemase genes among carbapenem-resistant
Wang TH; Leu YS; Wang NY; Liu CP; Yan TR
Antimicrob Resist Infect Control; 2018; 7():123. PubMed ID: 30338061
[TBL] [Abstract][Full Text] [Related]
25. Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates.
Opazo A; Sonnevend A; Lopes B; Hamouda A; Ghazawi A; Pal T; Amyes SG
J Antimicrob Chemother; 2012 Jul; 67(7):1619-22. PubMed ID: 22419799
[TBL] [Abstract][Full Text] [Related]
26. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.
Bogaerts P; Naas T; Wybo I; Bauraing C; Soetens O; Piérard D; Nordmann P; Glupczynski Y
J Clin Microbiol; 2006 Nov; 44(11):4189-92. PubMed ID: 16957031
[TBL] [Abstract][Full Text] [Related]
27. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of carbapenems resistance in Acinetobacter baumannii].
Wang H; Liu YM; Chen MJ; Sun HL; Xie XL; Xu YC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):567-72. PubMed ID: 14650160
[TBL] [Abstract][Full Text] [Related]
29. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan.
Chen CM; Liu PY; Ke SC; Wu HJ; Wu LT
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):394-7. PubMed ID: 19302926
[TBL] [Abstract][Full Text] [Related]
30. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
[TBL] [Abstract][Full Text] [Related]
31. [Dissemination of IMP-1 and OXA type beta-lactamase in carbapenem-resistant Acinetobacter baumannii].
Sung JY; Kwon KC; Park JW; Kim YS; Kim JM; Shin KS; Kim JW; Ko CS; Shin SY; Song JH; Koo SH
Korean J Lab Med; 2008 Feb; 28(1):16-23. PubMed ID: 18309251
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
Mostachio AK; Levin AS; Rizek C; Rossi F; Zerbini J; Costa SF
Int J Antimicrob Agents; 2012 May; 39(5):396-401. PubMed ID: 22455794
[TBL] [Abstract][Full Text] [Related]
33. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
34. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
35. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
Poirel L; Lebessi E; Héritier C; Patsoura A; Foustoukou M; Nordmann P
Clin Microbiol Infect; 2006 Nov; 12(11):1138-41. PubMed ID: 17002616
[TBL] [Abstract][Full Text] [Related]
36. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.
Fu Y; Zhou J; Zhou H; Yang Q; Wei Z; Yu Y; Li L
J Antimicrob Chemother; 2010 Apr; 65(4):644-50. PubMed ID: 20154023
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
Endo S; Yano H; Hirakata Y; Arai K; Kanamori H; Ogawa M; Shimojima M; Ishibashi N; Aoyagi T; Hatta M; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Kaku M
J Antimicrob Chemother; 2012 Jul; 67(7):1623-6. PubMed ID: 22447879
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
[TBL] [Abstract][Full Text] [Related]
39. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
[TBL] [Abstract][Full Text] [Related]
40. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
